RAIN THERAPEUTICS INC's ticker is RAIN and the CUSIP is 75082Q105. A total of 50 filers reported holding RAIN THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $78,551 | -48.5% | 91,148 | -28.2% | 0.00% | – |
| Q2 2023 | $152,392 | -36.8% | 126,993 | +360.3% | 0.00% | – |
| Q1 2023 | $241,154 | +105.1% | 27,592 | +87.8% | 0.00% | – |
| Q4 2022 | $117,568 | +80.9% | 14,696 | +10.4% | 0.00% | – |
| Q3 2022 | $65,000 | -18.8% | 13,315 | -8.4% | 0.00% | – |
| Q2 2022 | $80,000 | -87.1% | 14,530 | -88.1% | 0.00% | – |
| Q1 2022 | $618,000 | -33.5% | 121,824 | +69.0% | 0.00% | – |
| Q4 2021 | $929,000 | -10.9% | 72,097 | +3.4% | 0.00% | – |
| Q3 2021 | $1,043,000 | -12.0% | 69,693 | -8.6% | 0.00% | – |
| Q2 2021 | $1,185,000 | – | 76,272 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 2,034,552 | $1,753,377 | 0.54% |
| TANG CAPITAL MANAGEMENT LLC | 3,740,341 | $3,223,426 | 0.46% |
| PVG ASSET MANAGEMENT CORP | 47,520 | $40,952 | 0.28% |
| Acuitas Investments, LLC | 409,256 | $352,697 | 0.21% |
| Ghost Tree Capital, LLC | 325,000 | $280,085 | 0.09% |
| BVF INC/IL | 3,526,729 | $3,039,335 | 0.08% |
| BML Capital Management, LLC | 72,926 | $62,848 | 0.06% |
| Boxer Capital, LLC | 1,152,212 | $992,976 | 0.05% |
| Marquette Asset Management, LLC | 84,135 | $72,508 | 0.02% |
| Shay Capital LLC | 31,730 | $27,345 | 0.00% |